Fuller & Thaler Asset Management
NEO icon

Fuller & Thaler Asset Management’s NeoGenomics NEO Stock Holding History

Fuller & Thaler Asset Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-45,930
Closed -$341K – 532
2026
Q1 		$341K Buy
45,930
+1,150
+3% +$12.1K ﹤0.01% 465
2025
Q4 		$527K Sell
44,780
-1,050
-2% -$11.3K ﹤0.01% 435
2025
Q3 		$354K Hold
45,830
– – ﹤0.01% 469
2025
Q2 		$335K Buy
+45,830
New +$370K ﹤0.01% 468
2014
Q2 		– Sell
-299,850
Closed -$1.04M – 664
2014
Q1 		$1.04M Sell
299,850
-35,200
-11% -$132K 0.05% 262
2013
Q4 		$1.21M Buy
+335,050
New +$1.16M 0.07% 238

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Fuller & Thaler Asset Management's NEO Position: Q2 2026 in Review

Fuller & Thaler Asset Management sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 45,930 shares — an estimated $341K sold.

Fuller & Thaler Asset Management first reported a position in NEO in Q4 2013 and held it in 6 quarters. The position peaked at $1.21M in Q4 2013. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Fuller & Thaler Asset Management reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 45,930 NeoGenomics shares in Q2 2026, an estimated $341K.
  • Fuller & Thaler Asset Management first reported a position in NeoGenomics in Q4 2013 and held it in 6 quarters.
  • Fuller & Thaler Asset Management's NeoGenomics position peaked at $1.21M in Q4 2013.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.